Pancreatic Cancer Hepatitis B

Compared with individuals who have not infection of hepatitis b virus the pooled or of pancreatic cancer was 1 403 95 ci.

Pancreatic cancer hepatitis b. We report an acute reversible deterioration of liver function tests following cytotoxic chemotherapy in an hbsag positive patient with metastatic pancreatic cancer due to hepatitis b reactivation. Pancreatic cancer i e pancreatic ductal adenocarcinoma pdac is an important healthcare issue and a highly lethal disease. The aim of this study was to assess the role of hepatitis b hepb infection in the causation of pancreatic cancer and the predictors of pancreatic cancer and mortality. The finding suggests that hepatitis b already known to cause liver cancer in some patients may also increase the risk of pancreatic cancer one of the deadliest types of tumor.

Thus almost 80 of patients with pdac will die within one year after diagnosis. Purpose hepatitis b virus hbv and hepatitis c virus hcv are considered to be hepatotropic and are a major cause of hepatocellular carcinoma. Pancreatic cancer usually has a poor prognosis as in most cases by the time it is diagnosed it has already spread. There are several known risk factors for pancreatic cancer these include.

Patients and methods at the university of texas m. We identified pancreatic cancer patients 11 to 70 years of age from the 2013 2014 national inpatient sample. Several factors including smoking obesity advanced age diabetes mellitus and chronic panc. This study aimed to determine whether hbv and hcv infections increase the risk for pancreatic cancer development.

Exposure to the hepatitis b virus increases a person s risk of pancreatic cancer two and a half times. However little is known about the role of hbv and hcv infection in other malignancies. Exposure to the hepatitis b virus could increase the risk for pancreatic cancer and chemotherapy treatment might cause reactivation of the virus in cancer patients.